Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Blood|November 8, 2007
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemiaCarlo Visco, Marco Ruggeri, Maria Laura Evangelista, et al.
Hematological Oncology|February 25, 2022
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statementS Ferrero, Massimo Gentile, Luca Laurenti, et al.
Hematological Oncology|March 5, 2022
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statementPier Luigi Zinzani, Maurizio Martelli, S Ferrero, et al.
Annals of Hematology|March 23, 2016
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcomeGiuseppe Carli, Carlo Visco, Erika Falisi, et al.
Leukemia & Lymphoma|September 20, 2013
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?Carlo Visco, Agostino Cortelezzi, Francesca Moretta, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Tackling Mantle Cell Lymphoma in EuropeDenis Horgan, Jan Walewski, Igor Aurer, et al.
American Journal of Hematology|June 25, 2010
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patientsRoberta Zanotti, Franzesco Frattini, Paolo Ghia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantationCarlo Visco, Silvia Finotto, Renato Zambello, et al.
Critical Reviews in Oncology/Hematology|June 4, 2021
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysisCarlo Visco, Francesca Pregnolato, Isacco Ferrarini, et al.
Hematological Oncology|July 18, 2013
B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalitiesErika Falisi, Elisabetta Novella, Carlo Visco, et al.
Pageof 17